Avalo Therapeutics, Inc. (AVTX)
USD 9.28
(-1.07%)
USD 9.28
(-1.07%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.68 Million | -26.75 Million | -70.89 Million | -40.53 Million | -19.13 Million | -3.12 Million |
| Net Income | -31.54 Million | -41.65 Million | -84.37 Million | -63.49 Million | -16.07 Million | -40.05 Million |
| Depreciation & Amortization | 158 Thousand | 166 Thousand | 1.65 Million | 1.84 Million | 3.88 Million | 4.55 Million |
| Deferred income taxes | 14 Thousand | 28 Thousand | 22 Thousand | 195.58 Thousand | 16.74 Thousand | -16.74 Thousand |
| Stock-based compensation | 3.47 Million | 7.55 Million | 8.17 Million | 6.78 Million | 2.53 Million | 2.43 Million |
| Change in working capital | -9.24 Million | 4.77 Million | 2.83 Million | -4.43 Million | -2.02 Million | 8.73 Million |
| Other non-cash items | 6.45 Million | 2.38 Million | 794 Thousand | 18.57 Million | -7.46 Million | 21.22 Million |
| Investing Cash Flow | -133 Thousand | -95 Thousand | -113 Thousand | 11.13 Million | -443 Thousand | 865.46 Thousand |
| Investments in PPE | -158 Thousand | -95 Thousand | -113 Thousand | -62.65 Thousand | -262.01 Thousand | -564.41 Thousand |
| Acquisitions | 25 Thousand | - | - | 11.19 Million | 3.95 Million | 1.42 Million |
| Investment purchases | - | - | - | -11194.91 Billion | - | - |
| Sales/Maturities of investments | - | - | - | 12836.73 Billion | - | - |
| Other Investing Activities | -158 Thousand | - | - | -1641.81 Billion | -4.13 Million | -1000.00 |
| Financing Cash Flow | 25.04 Million | -14.69 Million | 106.76 Million | 44.78 Million | 12.55 Million | 10.4 Million |
| Debt repayment | -21.24 Million | -14.8 Million | -32.9 Million | - | -256.14 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 67 Thousand | -14.8 Million | 366 Thousand | -93.86 Thousand | -33.95 Thousand | - |
| Common Stock Issuance | 46.28 Million | 107 Thousand | 73.86 Million | 44.45 Million | 12.68 Million | 3.85 Million |
| Other Financing Activities | 46.28 Million | 107 Thousand | 73.86 Million | 426.26 Thousand | 1.24 Million | 6.54 Million |
| Accounts receivables | 1.78 Million | 1.06 Million | 1.11 Million | -678.1 Thousand | 1.65 Million | -222.53 Thousand |
| Accounts payables | -2.43 Million | -487 Thousand | 796 Thousand | 98.52 Thousand | 1.01 Million | 82.45 Thousand |
| Inventory | 20 Thousand | 18 Thousand | -35 Thousand | 18.19 Thousand | 532.94 Thousand | -311.19 Thousand |
| Other working capital | -8.6 Million | 4.17 Million | 961 Thousand | -3.87 Million | -5.23 Million | 9.18 Million |
| Cash at beginning of period | 13.18 Million | 54.86 Million | 19.1 Million | 3.72 Million | 10.74 Million | 2.6 Million |
| Cash at end of period | 7.41 Million | 13.31 Million | 54.86 Million | 19.1 Million | 3.72 Million | 10.74 Million |
| Capital Expenditure | -158 Thousand | -95 Thousand | -113 Thousand | -62.65 Thousand | -262.01 Thousand | -564.41 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -5.77 Million | -41.54 Million | 35.75 Million | 15.37 Million | -7.01 Million | 8.14 Million |
| Free Cash Flow | -30.83 Million | -26.84 Million | -71 Million | -40.6 Million | -19.39 Million | -3.69 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 98.46 Million | -121.29 Million | -8.16 Million | -31.54 Million | -5.22 Million | -8.19 Million |
| Depreciation & Amortization | 33 Thousand | 34 Thousand | 43 Thousand | 158 Thousand | 41 Thousand | 41 Thousand |
| Deferred income taxes | 7000.00 | 7000.00 | -9000.00 | 14 Thousand | 8000.00 | 7000.00 |
| Stock-based compensation | 471 Thousand | 629 Thousand | 776 Thousand | 3.47 Million | 953 Thousand | 893 Thousand |
| Change in working capital | -1.32 Million | -1.26 Million | 85 Thousand | -9.24 Million | -3.63 Million | -4.16 Million |
| Other non-cash items | -113.13 Million | 115.8 Million | 4.5 Million | 6.45 Million | 1.02 Million | 389 Thousand |
| Investing Cash Flow | - | 356 Thousand | -158 Thousand | -133 Thousand | - | 158 Thousand |
| Investments in PPE | - | - | -158 Thousand | -158 Thousand | - | 158 Thousand |
| Acquisitions | - | 356 Thousand | -25 Thousand | 25 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 356 Thousand | 158 Thousand | -158 Thousand | - | -158 Thousand |
| Financing Cash Flow | -472 Thousand | 108.61 Million | 1000.00 | 25.04 Million | 10.69 Million | 598 Thousand |
| Debt repayment | - | - | -21.24 Million | -21.24 Million | -15.24 Million | -6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 67 Thousand | 67 Thousand | - | - |
| Common Stock Issuance | - | 115.62 Million | 1000.00 | 46.28 Million | 25.93 Million | 6.59 Million |
| Other Financing Activities | -472 Thousand | 108.61 Million | 1000.00 | 46.28 Million | 25.93 Million | 598 Thousand |
| Accounts receivables | 2000.00 | 101 Thousand | 1.4 Million | 1.78 Million | 38 Thousand | -38 Thousand |
| Accounts payables | -262 Thousand | 470 Thousand | -342 Thousand | -2.43 Million | 37 Thousand | -4.81 Million |
| Inventory | - | - | - | 20 Thousand | 18 Thousand | 1000.00 |
| Other working capital | -1.06 Million | -1.83 Million | -975 Thousand | -8.6 Million | -3.73 Million | 688 Thousand |
| Cash at beginning of period | 110.18 Million | 7.41 Million | 10.18 Million | 13.18 Million | 6.45 Million | 16.88 Million |
| Cash at end of period | 93.42 Million | 110.18 Million | 7.41 Million | 7.41 Million | 10.31 Million | 6.45 Million |
| Capital Expenditure | - | - | -158 Thousand | -158 Thousand | - | 158 Thousand |
| Effect of forex changes on cash | - | - | 158 Thousand | - | - | -158 Thousand |
| Net cash flow / Change in cash | -16.75 Million | 102.76 Million | -2.76 Million | -5.77 Million | 3.85 Million | -10.42 Million |
| Free Cash Flow | -16.28 Million | -6.2 Million | -2.92 Million | -30.83 Million | -6.83 Million | -10.86 Million |
DE000A2NBN90
6489
WHI
PRECAM
300779
PAAS